Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case Report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39116355.
- Also identified by DOI 10.1200/PO.23.00649 and PMC identifier 11371073.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Trametinib, an MEK inhibitor, may offer a new therapeutic option for patients with NF1-related GIST.
Medical subject headings
- Gastrointestinal Stromal Tumors
- Neurofibromatosis 1
- Pyridones
- Pyrimidinones